Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 10, 2023, titled "Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 10, 2023, titled "Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules".